In the ever-evolving world of health and wellness, few breakthroughs have sparked as much excitement as the emergence of GLP-1/GIP therapies. These groundbreaking dual agonists are reshaping the landscape of obesity management and transforming the approach to a sustainable medical weight loss program. Within the first wave of clinical success, GLP-1 (glucagon-like peptide-1) and GIP...